Impact of a High Saturated Fat Diet on Fasted Systemic and White Adipose Tissue Inflammatory Responses
Impact of Short-term Overfeeding With a Saturated Fat-rich Diet on Fasted Systemic and White Adipose Tissue Inflammatory Responses
1 other identifier
interventional
15
1 country
1
Brief Summary
This study will investigate the effect of a 7-day westernised high-fat (65% of kilocalories), high-calorie (150% of requirements) diet on markers of inflammation in the blood and white adipose tissue. Participants will firstly complete a 3-day weight maintenance phase (Days 1-3) before completing a 7-day high fat diet intervention (Days 4-10). On days 4 and 11 participants will complete a laboratory visit where anthropometric measurements, blood and adipose samples will be collected. The investigators hypothesise that consuming a high-fat, high-calorie diet for 7 days will alter the inflammatory responses in white adipose tissue and will induce metabolic endotoxaemia / systemic inflammation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 22, 2018
CompletedFirst Posted
Study publicly available on registry
June 26, 2018
CompletedStudy Start
First participant enrolled
July 2, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 23, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
November 23, 2018
CompletedJanuary 4, 2019
January 1, 2019
5 months
May 22, 2018
January 3, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Protein expression (content and phosphorylation) of key markers of metabolic inflammation in white adipose tissue (for example assessment of NFKB/IKBa total protein and phosphorylation by western blot analysis)
This will be assessed following the collection of fasted white adipose tissue samples
Change between pre- and post-high fat diet (assessed on days 4 and 11)
Secondary Outcomes (8)
Systemic Markers of Inflammation (for example CRP, TNFa and IL-6 concentrations, determined by spectrophotometric assay/ ELISA)
Change between pre- and post-high fat diet (assessed on days 4 and 11)
Gene expression of key markers of metabolic inflammation in white adipose tissue
Change between pre- and post-high fat diet (assessed on days 4 and 11)
Fasting Serum Markers of Insulin Resistance (for example insulin and glucose concentrations, determined using an ELISA/ spectrophotometric assay)
Change between pre- and post-high fat diet (assessed on days 4 and 11)
Fasting Serum Lipid Profile (for example total, HDL and LDL cholesterol, TAG and NEFA concentrations, measured using a spectrophotometric assay)
Change between pre- and post-high fat diet (assessed on days 4 and 11)
Systemic Markers of Metabolic Endotoxemia (for example LBP and sCD14 concentrations, determined using an ELISA)
Change between pre- and post-high fat diet (assessed on days 4 and 11)
- +3 more secondary outcomes
Study Arms (1)
High Fat Diet
EXPERIMENTALParticipants will consume a high-fat, high-calorie diet for 7 days (i.e. westernised diet) following a 3-day weight maintenance diet. Measurements will be made pre- and post-high fat diet intervention.
Interventions
Participants will consume a high fat diet for 7 days with 65% of energy from fat. The diet will also provide an energy excess at 150% of energy requirements. Participants will be provided with all of their meals and snacks throughout the study.
Eligibility Criteria
You may qualify if:
- years
- BMI = 21.0-29.9 kg/m2
- Male or female
- Physically active (\> 3 x 30 min moderate exercise per week)
- Healthy
- No cardiometabolic (e.g. heart disease, high blood pressure, type 2 diabetes) or inflammatory illness
You may not qualify if:
- Inactive (\< 3 x 30 min moderate exercise per week)
- Smoker
- Women who are pregnant or lactating
- Medication/supplements known to interfere with study outcomes or prescribed antibiotics within the last 3 months
- Unstable weight history (≥3kg loss or gain in the previous 3 months)
- An allergy to lidocaine
- Food allergies (e.g. gluten, dairy) and intolerances (e.g. lactose) which could impede compliance to the diet
- Vegetarian/ vegan (as the high-fat diet is based on animal fats)
- Consumption of probiotics yogurts during or within the four weeks prior to the start of the study (e.g. Actimel, Activia, Yakult, Yeo Valley)
- Alcohol consumption \>28 units per week for a man (i.e. not more than 14 pints of beer or 28 small glasses of wine) or \>21 units per week for a woman (i.e. more than 10 and a half pints of beer or 21 small glasses of wine)
- Any other unusual medical history or diet and lifestyle habits or practices that would preclude volunteers from participating in a dietary intervention or metabolic study
- Restrained eaters (determined by Three Factor Eating Questionnaire)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Loughborough University
Loughborough, Leicestershire, LE11 3TU, United Kingdom
Related Publications (1)
Dewhurst-Trigg R, Wadley AJ, Woods RM, Sherar LB, Bishop NC, Hulston CJ, Markey O. Short-term High-fat Overfeeding Does Not Induce NF-kappaB Inflammatory Signaling in Subcutaneous White Adipose Tissue. J Clin Endocrinol Metab. 2020 Jul 1;105(7):dgaa158. doi: 10.1210/clinem/dgaa158.
PMID: 32232380DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Oonagh Markey, BSc, PhD
Loughborough University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 22, 2018
First Posted
June 26, 2018
Study Start
July 2, 2018
Primary Completion
November 23, 2018
Study Completion
November 23, 2018
Last Updated
January 4, 2019
Record last verified: 2019-01